Biomarker Proteasome Levels Predict Response To Combination Therapy With Carfilzomib, Lenalidomide, And Dexamethasone In Newly Diagnosed Multiple Myeloma Patients

BLOOD(2014)

引用 23|浏览7
暂无评分
摘要
Introduction
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要